Differential nitric oxide (NO) production by macrophages from mice and guinea pigs infected with virulent and avirulent Legionella pneumophila serogroup 1

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 48-53

  Rajagopalan Levasseur, P ^a   Lecointe, D ^a   Bertrand, G ^a   Fay, M ^a   Gougerot Pocidalo, M A ^a,b  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Legionella pneumophila; macrophages; mice; nitric oxide; virulence

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; LEGIONELLA PNEUMOPHILA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

EID: 0029949203     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-644.x     Document Type: Article

References (40)

1. Horwitz MA. Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J Exp Med 1983; 158:1319-31.
2. Horwitz MA, Maxfield FR. L. pneumophila inhibits acidification of its phagosome in human monocytes. J Cell Biol 1984; 99:1936-43.
3. Rajagopalan-Levasseur P, Dournon E, Vildé JL, Pocidalo JJ. Differences in the respiratory burst of human polymorphonuclear leukocytes induced by virulent and non virulent Legionella pneumophila serogroup 1. J Bioluminescence Chemiluminescence 1992; 7:109-16.
4. Summersgill TT, Raff MJ, Miller, RD. Interactions of virulent and avirulent Legionella pneumophila with human polymorphonuclear leukocytes. Microb Pathog 1988; 5:41-47.
5. Byrd TF, Horwitz MA. Interferon gamma-activated human monocytes down-regulate transferrin receptor and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest 1989; 83:1457-65.
6. Rajagopalan P, Dournon E, Vildé JL, Pocidalo JJ. Direct activation of human monocyte-derived macrophages by a bacterial glycoprotein extract inhibits the intracellular multiplication of virulent Legionella pneumophila serogroup 1. Infect Immun 1987; 55: 2234-9.
7. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-89.
8. Drapier JC, Wietzerbin J, Hibbs JB Jr. Interferon-γ and tumor necrosis factor induces the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18: 1587-92.
9. Granger DL, Hibbs JB Jr, Perfect JR, Durack DT. Metabolic fate of L-arginine in relation to microstatic capability of murine macrophages. J Clin Invest 1990; 85:264-73.
10. Hibbs JB Jr, Traintor RR, Vavrin Z. Macrophage cytotoxicity: role of L-arginine deiminase activity and imino nitrogen oxidation to nitrite. Science 1987; 235:473-6.
11. Hibbs JB Jr, Traintor RR, Vavrin Z, Granger DL, Drapier JC, Amber IJ, Lancaster RJ Jr. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: S. Moncada, Higgs EA, eds. Nitric oxide from L-arginine: a bioregulatory system. New York: Elsevier Science Publishers BV (Biochemical Division), 1990: 189-223.
12. Steuhr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiration inhibition in tumor target cells. J Exp Med 1989; 169:1543-55.
13. Adams LB, Hibbs Jr JB, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Imuunol 1990; 144:2725-9.
14. Sherman MP, Loro ML, WongVZ, Tashkin DP. Cytokine- and Pneumocystis carini-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991; 38:234S-236S.
15. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA. Leishmania major amistogotes initiate the L-arginine-dependent killing mechnisms in IFN-γ-stimulated macrophages by induction of TNF-α. J Immunol 1990; 145:4290-7.
16. r congenic mouse strain. Infect Immun 1991; 59:3935-44.
17. Rockett KA, Auburn MM, Cowden WB, Clark IA. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 1991; 59:3280-6.
18. James SL, Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 1989; 144:2738-44.
19. Vincendeau P, Daulouede S. Macrophages cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism. J Immunol 1991; 146:4338-43.
20. Vincendeau P, Daulouede S, Veyret B, Darde ML, Bouteille B, Lemesre JL. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol 1992; 75:353-60.
21. Denis M, Ghadirian E. Activated mouse macrophages kill Entamoeba histolytica trophozoites by releasing reactive nitrogen intermediates. Microb Path 1992; 12:193-8.
22. Fischer-Stenger K, Marciano-Cabral F. The arginine-dependent cytolytic mechanism plays a role in destruction of Naegleria fowleri amoebae by activated macrophages. Infect Immun 1992; 60: 5126-31.
23. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue, ER. Release of nitric oxide during the T cell-independent pathway macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol 1993; 150:888-95.
24. Green SJ, Nacy CA, Schreiber RD, Granger DL, Crawford RM, Meltzer MS, Fortier AH. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacteriurn bovis BCG-treated mice. Infect Immun 1993; 61:689-98.
25. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-22.
26. Adams LB, Franzblau SG, Vavrin Z, Hibbs Jr JB, Krahenbuhl JL. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol 1991; 147: 1642-6.
27. Denis M. Tumor necrosis factor and granulocyte macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49:380-7.
28. Summersgill JT, Powell LA, Buster BL, Miller RD, Ramirez JA. Killing of Legionella pneumophila by nitric oxide in γ-interferon-activated macrophages. J Leukocyte Biol 1992; 52:625-9.
29. Darius H, Grodzinska L, Meyer J. The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leukocyte function in vitro and ex vivo. Eur J Clin Pharmocol 1992; 43:629-33.
30. Dournon E, Bibb WB, Rajagopalan P, Desplaces N, McKinney RM. Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains. J Infect Dis 1988; 157: 496-501.
31. Petitjean F, Dournon E, Strosberg AD, Hoebeke J. Isolation, purification, and partial analysis of the lipopolysaccharide antigenic determinant recognized by a monoclonal antibody to Legionella pneumophila serogroup 1. Res Microbiol 1991; 141:1077-94.
32. Ciesielski CA, Blaser MJ, Wang WLL. Serogroup specificity of Legionella pneumophila is related to lipolysaccharide characteristics. Infect Immun 1986; 51:397-404.
33. Gebran SJ, Yamamoto Y, Newton C, Klein TW, Friedman H. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron (III). Infect Immun 1994; 62:3197-205.
34. Locksley RM, Jacobs RF, Wilson CB, Weaver WM, Klebanoff SJ. Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems. J Immunol 1982; 129:2192-7.
35. Byrd TF, Horwitz MA. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes: coordinate upregulation by iron-transferrin and downregulation by interferon gamma. J Clin Invest 1993; 91:969-76.
36. Lepoivre M, Fiesch F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophy Res Commun 1991; 179:442-8.
37. Drapier JC, Hirling H, Wietzerbin J, Kaldy P, Kühn LC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J 1993; 12:3643-9.
38. Alford CE, King Jr TE, Campbell PA. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med 1991; 174:459-66.
39. Mayer J, Woods ML, Vavrin Z, Hibbs JB Jr. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun 1993; 61:491-7.
40. Murray HW, Teitlebaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 1992; 165:513-7.